IPO Timeline Raw facts
Broker Results (T-2)
2025-08-05
Some brokers release in afternoon
Grey Market (T-1)
2025-08-06
Afternoon
HKEX Allotment (T-1)
2025-08-06
Evening
Registrar Allotment (T-1)
2025-08-06
Evening
Listing Day (T)
2025-08-07
First day of trading
Company Overview
| Stock Name | Sunshine Pharma |
|---|---|
| Stock Code | 06887 |
| Company Full Name | Sunshine Lake Pharma Co., Ltd. |
| Industry | Healthcare |
| Principal Activities | A comprehensive pharmaceutical company engaged in the research and development, production and commercialization of drugs, focusing on therapeutic areas such as infectious diseases, chronic diseases and oncology. |
| Listing Date | 2025-08-07 |
| Listing Rules Era | New Rules (after Aug 2025) |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省東莞市松山湖園區工業北路1號 |
| Business Address (Hong Kong) | 香港灣仔皇后大道東248號大新金融中心40樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | hecpharm.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | 卓佳证券登记有限公司，香港金钟道89号力宝中心1座31楼3101-3103室 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | To be extracted |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 1.0 / shares |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | 576,656,047 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | To be extracted |
Stock Connect Inclusion
| HK Market Cap | HK$ 14.2B |
|---|
| 26Q2 Regular Review | |
| Inclusion Pathway | Small Cap Regular Path |
|---|---|
| Est. Threshold | HK$ 10.47B Met |
| Analysis Result | 预计2026年9月7日入通 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not applicable (loss-making) |
| Profit/Loss Status | Net profit RMB 24.8 million |
| Period-End Cash Balance | RMB 1,480.81 million |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | Loading... |
|---|
Underwriting Syndicate
Sponsor
中國國際金融香港證券有限公司
Reporting Accountant
畢馬威會計師事務所
Property Valuer
不適用
Cornerstone Investors
No data
Directors & Management
| Chairman | 張英俊 |
|---|---|
| Company Secretary | 鄭程傑 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | The controlling shareholders are a group of shareholders including Mr. Zhang, Ms. Guo, Guangdong Dongyangguang Technology and others, who directly or indirectly control 50.98% of the voting rights of the Company immediately after the Listing. |
|---|
